Deanna H. Pafundi, Ph.D.

Closed for Enrollment

• Utility of 18F-DOPA PET Metrics as a Biomarker for Treatment Response Assessment In Sarcoma Patients: A Pilot Study (GMROF2181) Jacksonville, Fla.

  The purpose of this study is to identify early response biomarkers from biological or functional imaging to better align with clinical trial endpoints and minimize sarcoma patient toxicities.